$STOK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Stoke Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Stoke Therapeutics, Inc.. Get notifications about new insider transactions in Stoke Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | A | 60.00 | 200,800 | 12,048,000 | 200,800 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.60 | 7,882 | 4,729 | 8,764 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.40 | 1,842 | 737 | 0 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.40 | 2,776 | 1,110 | 0 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Sell | S | 61.14 | 4,957 | 303,087 | 0 | 5 K to 0 (-100.00 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Sell | S | 60.55 | 7,543 | 456,754 | 4,957 | 12.5 K to 5 K (-60.34 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.60 | 7,882 | 4,729 | 12,500 | 4.6 K to 12.5 K (+170.68 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.40 | 1,842 | 737 | 4,618 | 2.8 K to 4.6 K (+66.35 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.40 | 2,776 | 1,110 | 2,776 | 0 to 2.8 K |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 5,000 | 22,400 | 179,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 25,000 | 112,000 | 184,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.60 | 5,000 | 292,992 | 602 | 5.6 K to 602 (-89.25 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 5,000 | 22,400 | 5,602 | 602 to 5.6 K (+830.56 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 60.00 | 102 | 6,120 | 602 | 704 to 602 (-14.49 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 59.29 | 9,696 | 574,842 | 704 | 10.4 K to 704 (-93.23 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.67 | 15,202 | 891,942 | 10,400 | 25.6 K to 10.4 K (-59.38 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 25,000 | 112,000 | 25,602 | 602 to 25.6 K (+4,152.82 %) |
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | M | 2.19 | 10,000 | 21,900 | 13,447 | |
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Sell | S | 60.67 | 10,000 | 606,652 | 0 | 10 K to 0 (-100.00 %) |
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Buy | M | 2.19 | 10,000 | 21,900 | 10,000 | 0 to 10 K |
| Jan 27 2021 | STOK | Stoke Therapeutics ... | Menzel Garry E | Director | Option Exercise | A | 28.57 | 29,555 | 844,386 | 29,555 | |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 5,700 | 12,483 | 125,397 | |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 57.14 | 32 | 1,828 | 0 | 32 to 0 (-100.00 %) |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 60.51 | 200 | 12,102 | 32 | 232 to 32 (-86.21 %) |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 59.85 | 1,800 | 107,724 | 232 | 2 K to 232 (-88.58 %) |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 59.02 | 2,200 | 129,837 | 2,032 | 4.2 K to 2 K (-51.98 %) |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 57.66 | 1,500 | 86,494 | 4,232 | 5.7 K to 4.2 K (-26.17 %) |
| Jan 06 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 5,700 | 12,483 | 5,732 | 32 to 5.7 K (+17,812.50 %) |
| Jan 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 637,801 | |
| Jan 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 10,000 | 0 to 10 K |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | M | 2.19 | 1,365 | 2,989 | 84,400 | |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 59.00 | 365 | 21,534 | 173,402 | 173.8 K to 173.4 K (-0.21 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 58.02 | 286 | 16,593 | 173,767 | 174.1 K to 173.8 K (-0.16 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 56.76 | 714 | 40,527 | 174,053 | 174.8 K to 174.1 K (-0.41 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Buy | M | 2.19 | 1,365 | 2,989 | 174,767 | 173.4 K to 174.8 K (+0.79 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | M | 2.19 | 1,365 | 2,989 | 84,400 | |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 59.00 | 365 | 21,534 | 173,402 | 173.8 K to 173.4 K (-0.21 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 58.02 | 286 | 16,593 | 173,767 | 174.1 K to 173.8 K (-0.16 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 56.76 | 714 | 40,527 | 174,053 | 174.8 K to 174.1 K (-0.41 %) |
| Dec 21 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Buy | M | 2.19 | 1,365 | 2,989 | 174,767 | 173.4 K to 174.8 K (+0.79 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Sell | S | 60.00 | 5,194 | 311,640 | 0 | 5.2 K to 0 (-100.00 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Sell | S | 60.00 | 19,806 | 1,188,360 | 5,194 | 25 K to 5.2 K (-79.22 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.60 | 8,015 | 4,809 | 172,371 | |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.60 | 8,015 | 4,809 | 172,371 | |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.60 | 41,985 | 25,191 | 180,386 | |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.60 | 41,985 | 25,191 | 180,386 | |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 60.00 | 8,015 | 480,900 | 0 | 8 K to 0 (-100.00 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 60.00 | 8,015 | 480,900 | 0 | 8 K to 0 (-100.00 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.60 | 8,015 | 4,809 | 8,015 | 0 to 8 K |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.60 | 8,015 | 4,809 | 8,015 | 0 to 8 K |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 60.00 | 41,985 | 2,519,100 | 0 | 42 K to 0 (-100.00 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 60.00 | 41,985 | 2,519,100 | 0 | 42 K to 0 (-100.00 %) |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.60 | 41,985 | 25,191 | 41,985 | 0 to 42 K |
| Dec 18 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.60 | 41,985 | 25,191 | 41,985 | 0 to 42 K |
| Nov 30 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Sell | S | 50.00 | 12,152 | 607,600 | 25,000 | 37.2 K to 25 K (-32.71 %) |
| Nov 25 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Sell | S | 50.00 | 12,848 | 642,400 | 37,152 | 50 K to 37.2 K (-25.70 %) |
| Nov 25 2020 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 39.00 | 375,000 | 14,625,000 | 17,161,713 | 16.8 M to 17.2 M (+2.23 %) |
| Nov 25 2020 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Buy | P | 39.00 | 375,000 | 14,625,000 | 17,161,713 | 16.8 M to 17.2 M (+2.23 %) |
| Nov 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 13,414 | 29,377 | 136,797 | |
| Nov 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.60 | 36,586 | 21,952 | 222,371 | |
| Nov 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 45.00 | 50,000 | 2,250,000 | 0 | 50 K to 0 (-100.00 %) |
| Nov 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 13,414 | 29,377 | 50,000 | 36.6 K to 50 K (+36.66 %) |
| Nov 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.60 | 36,586 | 21,952 | 36,586 | 0 to 36.6 K |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 33,268 | 149,041 | 209,997 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 1,732 | 7,759 | 243,265 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 35,000 | 156,800 | 244,997 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 41.97 | 5,216 | 218,910 | 602 | 5.8 K to 602 (-89.65 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 41.42 | 11,111 | 460,214 | 5,818 | 16.9 K to 5.8 K (-65.63 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 40.03 | 16,941 | 678,086 | 16,929 | 33.9 K to 16.9 K (-50.02 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 33,268 | 149,041 | 33,870 | 602 to 33.9 K (+5,526.25 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 39.84 | 1,732 | 68,998 | 602 | 2.3 K to 602 (-74.21 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 1,732 | 7,759 | 2,334 | 602 to 2.3 K (+287.71 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 38.44 | 400 | 15,374 | 602 | 1 K to 602 (-39.92 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 37.86 | 14,445 | 546,909 | 1,002 | 15.4 K to 1 K (-93.51 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 36.79 | 20,155 | 741,448 | 15,447 | 35.6 K to 15.4 K (-56.61 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 35,000 | 156,800 | 35,602 | 602 to 35.6 K (+5,813.95 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 5,700 | 12,483 | 150,211 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 37.98 | 2,536 | 96,325 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 36.59 | 3,164 | 115,785 | 2,536 | 5.7 K to 2.5 K (-55.51 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 5,700 | 12,483 | 5,700 | 0 to 5.7 K |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 2.19 | 1,503 | 3,292 | 70,386 | |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 30,497 | 18,298 | 96,069 | |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 5,851 | 3,511 | 126,566 | |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 38.42 | 7,225 | 277,586 | 13,500 | 20.7 K to 13.5 K (-34.86 %) |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 37.64 | 24,775 | 932,578 | 20,725 | 45.5 K to 20.7 K (-54.45 %) |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 2.19 | 1,503 | 3,292 | 45,500 | 44 K to 45.5 K (+3.42 %) |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 30,497 | 18,298 | 43,997 | 13.5 K to 44 K (+225.90 %) |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 40.00 | 5,851 | 234,042 | 13,500 | 19.4 K to 13.5 K (-30.24 %) |
| Oct 20 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 5,851 | 3,511 | 19,351 | 13.5 K to 19.4 K (+43.34 %) |
| Oct 13 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 1,649 | 989 | 132,417 | |
| Oct 13 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 40.00 | 1,649 | 65,960 | 13,500 | 15.1 K to 13.5 K (-10.89 %) |
| Oct 13 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 1,649 | 989 | 15,149 | 13.5 K to 15.1 K (+12.21 %) |
| Oct 05 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 5,700 | 12,483 | 155,911 | |
| Oct 05 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 34.86 | 2,300 | 80,183 | 0 | 2.3 K to 0 (-100.00 %) |
| Oct 05 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 34.33 | 3,400 | 116,718 | 2,300 | 5.7 K to 2.3 K (-59.65 %) |
| Oct 05 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 5,700 | 12,483 | 5,700 | 0 to 5.7 K |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 17,201 | 37,670 | 161,611 | |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 30,718 | 67,272 | 178,812 | |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 30.00 | 17,201 | 516,030 | 0 | 17.2 K to 0 (-100.00 %) |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 17,201 | 37,670 | 17,201 | 0 to 17.2 K |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 30.00 | 30,718 | 921,540 | 0 | 30.7 K to 0 (-100.00 %) |
| Sep 10 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 30,718 | 67,272 | 30,718 | 0 to 30.7 K |
| Sep 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 5,700 | 12,483 | 209,530 | |
| Sep 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 28.71 | 700 | 20,098 | 0 | 700 to 0 (-100.00 %) |
| Sep 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 27.60 | 5,000 | 138,015 | 700 | 5.7 K to 700 (-87.72 %) |
| Sep 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 5,700 | 12,483 | 5,700 | 0 to 5.7 K |
| Aug 31 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 2,081 | 4,557 | 215,230 | |
| Aug 31 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 30.00 | 2,081 | 62,430 | 0 | 2.1 K to 0 (-100.00 %) |
| Aug 31 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 2,081 | 4,557 | 2,081 | 0 to 2.1 K |
| Aug 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 5,700 | 12,483 | 217,311 | |
| Aug 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 24.73 | 5,700 | 140,943 | 0 | 5.7 K to 0 (-100.00 %) |
| Aug 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 5,700 | 12,483 | 5,700 | 0 to 5.7 K |
| Jul 17 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 1,900 | 4,161 | 223,011 | |
| Jul 17 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 25.06 | 1,900 | 47,614 | 0 | 1.9 K to 0 (-100.00 %) |
| Jul 17 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 1,900 | 4,161 | 1,900 | 0 to 1.9 K |
| Jul 09 2020 | STOK | Stoke Therapeutics ... | Walker Robin A. | Chief Legal Officer ... | Sell | S | 22.50 | 941 | 21,173 | 0 | 941 to 0 (-100.00 %) |
| Jul 09 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 22.41 | 913 | 20,457 | 0 | 913 to 0 (-100.00 %) |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | Smith Julie | Director | Option Exercise | A | 26.53 | 29,555 | 784,094 | 29,555 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | Krainer Adrian R. | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | Burstein Jennifer | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | M | 2.19 | 42,880 | 93,907 | 85,765 | |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | M | 0.60 | 131,147 | 78,688 | 85,946 | |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 27.98 | 365 | 10,213 | 172,662 | 173 K to 172.7 K (-0.21 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Sell | S | 27.17 | 1,000 | 27,174 | 173,027 | 174 K to 173 K (-0.57 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Buy | M | 2.19 | 42,880 | 93,907 | 174,027 | 131.1 K to 174 K (+32.70 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Buy | M | 0.60 | 131,147 | 78,688 | 131,147 | 0 to 131.1 K |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 2.19 | 20,000 | 43,800 | 71,889 | |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 27.48 | 1,230 | 33,802 | 13,500 | 14.7 K to 13.5 K (-8.35 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 26.91 | 7,875 | 211,921 | 14,730 | 22.6 K to 14.7 K (-34.84 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 25.82 | 10,895 | 281,314 | 22,605 | 33.5 K to 22.6 K (-32.52 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 2.19 | 20,000 | 43,800 | 33,500 | 13.5 K to 33.5 K (+148.15 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 2,107 | 4,614 | 228,711 | |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 27.48 | 500 | 13,742 | 0 | 500 to 0 (-100.00 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 27.08 | 1,607 | 43,521 | 500 | 2.1 K to 500 (-76.27 %) |
| Jun 03 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 2,107 | 4,614 | 2,107 | 0 to 2.1 K |
| May 26 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 7,500 | 4,500 | 134,066 | |
| May 26 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Sell | S | 30.00 | 7,500 | 225,000 | 13,500 | 21 K to 13.5 K (-35.71 %) |
| May 26 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 7,500 | 4,500 | 21,000 | 13.5 K to 21 K (+55.56 %) |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 7,500 | 4,500 | 141,566 | |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | M | 0.60 | 6,000 | 3,600 | 149,066 | |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 7,500 | 4,500 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Buy | M | 0.60 | 6,000 | 3,600 | 6,000 | 0 to 6 K |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | M | 0.60 | 50,000 | 30,000 | 647,801 | |
| Apr 15 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Buy | M | 0.60 | 50,000 | 30,000 | 50,000 | 0 to 50 K |